Results 41 to 50 of about 342,764 (287)

CRISPR/Cas9‐mediated genome editing: from basic research to translational medicine [PDF]

open access: yes, 2020
The recent development of the CRISPR/Cas9 system as an efficient and accessible programmable genome-editing tool has revolutionized basic science research. CRISPR/Cas9 system-based technologies have armed researchers with new powerful tools to unveil the
Ferreira, B I   +2 more
core   +1 more source

Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis

open access: yesEBioMedicine, 2015
The global tuberculosis (TB) epidemic and the spread of multi- and extensively-drug resistant strains of Mycobacterium tuberculosis (M.tb) have been fueled by low adherence to following lengthy treatment protocols, and the rapid spread of HIV (Human ...
Mamoudou Maiga   +7 more
doaj   +1 more source

Pathogen- and Host-Directed Antileishmanial Effects Mediated by Polyhexanide (PHMB) [PDF]

open access: yes, 2015
BACKGROUND:Cutaneous leishmaniasis (CL) is a neglected tropical disease caused by protozoan parasites of the genus Leishmania. CL causes enormous suffering in many countries worldwide. There is no licensed vaccine against CL, and the chemotherapy options
A Ponte-Sucre   +63 more
core   +4 more sources

Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. [PDF]

open access: yes, 1985
Autoimmune NZB/NZW mice were treated with weekly injections of monoclonal antibody (mAb) to L3T4, an antigen expressed on a distinct subpopulation of T cells that respond to class II major histocompatibility antigens.
Seaman, WE, Wofsy, D
core   +1 more source

Modulating Iron for Metabolic Support of TB Host Defense

open access: yesFrontiers in Immunology, 2018
Tuberculosis (TB) is the world's biggest infectious disease killer. The increasing prevalence of multidrug-resistant and extensively drug-resistant TB demonstrates that current treatments are inadequate and there is an urgent need for novel therapies ...
James J. Phelan   +5 more
doaj   +1 more source

Complex regulation of neutrophil-derived MMP-9 secretion in central nervous system tuberculosis. [PDF]

open access: yes, 2017
BACKGROUND: Central nervous system tuberculosis (CNS-TB) may be fatal even with treatment. Neutrophils are the key mediators of TB immunopathology, and raised CSF matrix metalloproteinase-9 (MMP-9) which correlates to neutrophil count in CNS-TB is ...
Brilha, S   +6 more
core   +1 more source

Natriuretic peptide-directed medical therapy: a systematic review

open access: yesPerioperative Medicine, 2020
Natriuretic peptides (NP) are strongly associated with perioperative cardiovascular events. However, in patients with raised NP, it remains unknown whether treatment to reduce NP levels prior to surgery results in better perioperative outcomes.
Christella S. Alphonsus   +3 more
doaj   +1 more source

Host-directed therapies for bacterial and viral infections

open access: greenNature Reviews Drug Discovery, 2017
Stefan H. E. Kaufmann   +3 more
openalex   +4 more sources

RNA interference approaches for treatment of HIV-1 infection. [PDF]

open access: yes, 2015
HIV/AIDS is a chronic and debilitating disease that cannot be cured with current antiretroviral drugs. While combinatorial antiretroviral therapy (cART) can potently suppress HIV-1 replication and delay the onset of AIDS, viral mutagenesis often leads to
Bobbin, Maggie L   +2 more
core   +1 more source

Host-directed therapies for multidrug resistant tuberculosis

open access: yesInternational Journal of Mycobacteriology, 2016
Tuberculosis (TB) causes 1.3 million deaths annually. There are 0.5 million cases of multidrug resistant TB (MDR-TB) and the number of cases is rising globally.
Alimuddin Zumla, Markus Maeurer
doaj   +1 more source

Home - About - Disclaimer - Privacy